Biocon Limited (NSE:BIOCON)

Biocon Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	32,271	12,336	13,235	6,630	9,531
Short-Term Investments	8,907	10,248	19,585	20,501	16,470
Trading Asset Securities	4,473	3,156	4,443	2,518	6,237
Cash & Short-Term Investments	45,651	25,740	37,263	29,649	32,238
Cash Growth	77.35%	-30.92%	25.68%	-8.03%	73.70%
Accounts Receivable	54,879	62,306	35,732	20,582	15,097
Other Receivables	964	389	1,321	4,506	5,071
Receivables	55,843	62,695	37,053	25,759	20,168
Inventory	49,311	49,439	42,437	22,982	18,666
Prepaid Expenses	1,899	1,571	1,316	873	705
Other Current Assets	10,158	12,347	5,271	4,560	4,227
Total Current Assets	162,862	151,792	123,340	83,823	76,004
Property, Plant & Equipment	134,141	119,778	101,226	93,643	79,641
Long-Term Investments	6,815	6,843	8,673	3,702	8,821
Goodwill	167,857	163,724	161,362	264	264
Other Intangible Assets	102,719	102,867	105,259	12,887	11,736
Long-Term Deferred Tax Assets	2,577	3,173	3,010	2,933	3,077
Other Long-Term Assets	11,002	12,530	17,558	6,688	5,680
Total Assets	587,973	560,707	520,428	203,940	185,223
Accounts Payable	65,487	62,720	38,420	16,085	15,139
Accrued Expenses	6,573	2,906	4,840	1,741	1,700
Short-Term Debt	53,501	27,972	24,802	8,962	6,037
Current Portion of Long-Term Debt	-	-	-	95	8,028
Current Portion of Leases	674	547	390	211	84
Current Income Taxes Payable	1,731	2,769	2,250	1,618	1,524
Current Unearned Revenue	1,452	1,176	1,915	1,053	1,030
Other Current Liabilities	13,920	55,498	12,490	8,515	8,559
Total Current Liabilities	143,338	153,588	85,107	38,280	42,101
Long-Term Debt	124,054	129,324	152,905	39,985	29,616
Long-Term Leases	5,391	4,924	2,091	2,215	1,141
Long-Term Unearned Revenue	3,366	3,107	2,901	12,151	10,253
Long-Term Deferred Tax Liabilities	3,577	3,915	3,818	523	323
Other Long-Term Liabilities	29,908	12,000	47,684	15,169	15,651
Total Liabilities	310,848	307,959	295,540	109,240	100,147
Common Stock	6,003	6,003	6,003	6,003	6,000
Additional Paid-In Capital	2,581	2,285	1,735	1,192	619
Retained Earnings	191,469	177,906	162,476	69,890	63,975
Treasury Stock	-784	-971	-971	-324	-1,343
Comprehensive Income & Other	17,171	12,614	9,426	7,564	7,018
Total Common Equity	216,440	197,837	178,669	84,325	76,269
Minority Interest	60,685	54,911	46,219	10,375	8,807
Shareholders' Equity	277,125	252,748	224,888	94,700	85,076
Total Liabilities & Equity	587,973	560,707	520,428	203,940	185,223
Total Debt	183,620	162,767	180,188	51,468	44,906
Net Cash (Debt)	-137,969	-137,027	-142,925	-21,819	-12,668
Net Cash Per Share	-115.15	-114.49	-119.51	-18.24	-10.59
Filing Date Shares Outstanding	1,198	1,197	1,194	1,193	1,189
Total Common Shares Outstanding	1,198	1,197	1,194	1,193	1,189
Working Capital	19,524	-1,796	38,233	45,543	33,903
Book Value Per Share	180.66	165.30	149.64	70.68	64.15
Tangible Book Value	-54,136	-68,754	-87,952	71,174	64,269
Tangible Book Value Per Share	-45.19	-57.45	-73.66	59.66	54.06
Land	3,726	3,373	2,918	2,805	2,695
Buildings	26,492	23,170	20,814	19,766	18,880
Machinery	120,289	103,389	97,262	76,553	69,865
Construction In Progress	41,017	39,852	25,875	34,203	22,535
Leasehold Improvements	3,619	2,686	2,518	116	81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.